| Application no. and date | 17742898.4 (espacenet) (Federated) (European Patent Register), 20170707 | | Patent/reg. no. and date | DK/EP 3481852, 20221207 | | Publication date | 20190515 | | Priority no. and date | US 201662360239 P, 20160708 | | EP pub. no. and date |
EP 3481852 20190515 | | Effective date | | | Applicant/owner | Children's Medical Center Corporation, 55 Shattuck Street
Boston, MA 02115, US,
Stenmark, Paul, Svantearrheniusvag 16c
10691 Stockholm, SE | | Applicant ref. no. | 1656067 | | Inventor | DONG, Min, 12 Croft Lane
Weatogue, CT 06089, US,
STENMARK, Paul, Svantearrheniusvag 16c
10691 Stockholm, SE,
ZHANG, Sicai, EN 1070
300 Longwood Ave
Boston, MA, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , C07K 14/33 (2006.01) , C12N 5/00 (2006.01) | | Title | HIDTIL UKENDT BOTULINUM-NEUROTOKSIN OG DETS DERIVATER | | Int. application no. | US2017041255 | | Int. publication no. | WO2018009903 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
